Financial Reports and Publications - Sanofi
WEBDownload PDF. Find out global pharmaceutical and healthcare company Sanofi financial reports and publications.
Capital Markets Day 2021 - Sanofi
WEBCapital Markets Day 2021. Sanofi hosted a virtual Capital Markets Day on February 5, 2021.
Soliqua® Phase 3 results significantly lowered blood sugar
WEBJun 9, 2017 · Soliqua ® is an injectable prescription medicine that contains two diabetes medicines, insulin glargine and lixisenatide. Soliqua ® is marketed in the EU as Suliqua ®, where it is indicated in combination with metformin for the treatment of adults with type 2 diabetes mellitus to improve glycemic control when this has not been provided by …
Medicines - Sanofi
WEBGeneral Medicine Focus Areas. Cardiovascular Diseases. Diabetes. Continue to vaccines. Global pharmaceutical and healthcare company Sanofi's specialty care & general medicines focus areas.
Sanofi to resume dosing in fitusiran clinical studies in the U.S.
WEBDec 10, 2020 · Sanofi will resume fitusiran dosing in ongoing U.S. adolescent and adult clinical studies. Fitusiran is an investigational, small interference RNA therapy in development for the treatment of people with hemophilia A or B, with or without inhibitors. Sanofi’s first priority is patient safety. The company voluntarily paused dosing in all ...
Sanofi stock chart
WEB3 days ago · Sanofi stock chart. Ticker table to check the latest price updates. Date & Time: 03 July 2024 17:37 (GMT+02:00) Share. Market. Last.
Contact - Sanofi
WEBSanofi is present in more than 70 countries worldwide. We invite you to directly consult the site of your country by clicking here. If, however, your country is not in this list, you can contact us by completing the form below. Use the contact form for comments or questions concerning our company. Please note that this form is not to be used to ...
US FDA approves fexinidazole as the first all-oral treatment for ...
WEBJul 19, 2005 · The US Food and Drug Administration (FDA) has approved fexinidazole as the first all-oral treatment for both stages of the Trypanosoma brucei gambiense form of sleeping sickness (Human African trypanosomiasis) in patients 6 years of age and older and weighing at least 20 kg. Fexinidazole was developed as part of an innovative partnership ...
Consumer Healthcare - Sanofi
WEBAt Consumer Healthcare at Sanofi, we're building a healthier future by helping people, help themselves. We empower people to champion better self-care for themselves, their communities and our planet, through our consumer-inspired, science-based products and solutions. Through our brands, we elevate creativity and make health as simple as it ...
Diabetes - Sanofi
WEBDiabetes is a chronic condition affecting the body’s ability to effectively process and convert sugar into energy. People with type 1 diabetes do not produce insulin, a hormone made by the pancreas. People with type 2 diabetes do not respond to insulin as well as they should, or do not make enough of it. 2 This leads to raised glucose levels ...
Skip to content